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BACKGROUND
PURPOSE
REFERENCES
This was a single center, prospective, survey-based study at a 
small community hospital infusion center that consists of 
approximately five chairs. An oncology pharmacy specialist was 
available to provide counseling and education to patients while in 
the infusion center three days of the week. When the oncology 
specialist was unavailable, counseling was performed by other 
clinical specialists on staff. A standard chemotherapy handout was 
developed and one website (www.chemocare.com) was used to 
print drug handouts for patients. All clinical specialists at the 
hospital received training on the use of these handouts. 
The study consisted of 15 patients, over the course of six 
months (April-October 2016). Counseling and education was 
completed at the beginning and middle of each patient’s 
chemotherapy cycle. At the end of the cycle, a Likert-scale and 
short answer survey was administered to determine patient 
satisfaction and whether any hospitalizations occurred. 
All patients participating in the study were asked for permission to 
be counseled and whether they would want to fill out the survey at 
the end of their cycle. To be included in the study, patients only 
had to receive chemotherapy in the infusion center being studied.
RESULTS
New and complicated chemotherapy regimens require educated 
physicians, nurses, and pharmacists for patient counseling. 
Oncology pharmacists’ counseling plays a key role in patient 
education. Based on the results of the survey, patients at North 
Fulton Hospital felt confident in their knowledge of the 
chemotherapy regimen, of what to do in the occurrence of side 
effects, and how/why their drugs work. In regards to Emergency 
Department admissions, half of them were “good admissions” 
based on pharmacists’ recommendations; and the other half were 
before counseling, due to patient non adherence to 
recommendations or uncontrolled antiemetic therapy. 
Some limitations of this study include the small population, 
various pharmacists giving counseling information, and not every 
pharmacist who counseled was trained in oncology. Time was 
also a limitation for many pharmacists due to their other clinical 
responsibilities, so some patients we not counseled until the 2nd
or 3rd cycle of chemotherapy. If oncology patients were admitted 
to any other ED than North Fulton without relaying this 
information, these admissions may not have been included in the 
study for lack of knowledge. If patients reported side effects to 
their oncologists only, there was no direct communication 
between pharmacy and oncologists, so these side effects may be 
missed in reporting. 
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METHODS
Cancer is increasing worldwide and more and more people 
have received chemotherapy treatment. Chemotherapy agents 
are cytotoxic drugs that kill cancer cells. Due to the increase in 
cancer, there has also been in an increase in research for cancer 
medications. For most people, the diagnosis of cancer causes 
many psychological and emotional effects which make it difficult to 
accept the ramifications of disease and treatment process. There 
are several support groups that patients can attend, but studies 
have shown that educating patients about cancer and 
chemotherapy in general can increase the patient’s compliance 
and satisfaction as well as decrease side effects and 
hospitalizations. Pharmacists can offer teaching and education to 
these patients and their families to help decrease anxiety and 
complications.1
. 
The purpose of this study is to determine patient satisfaction 
after being counseled by a pharmacist as well as to see if education 
decreased any hospitalizations while the patient was receiving 
treatment.
Eight patients completed the survey from the fifteen total patients enrolled. The results are shown above. 
Nine patients were analyzed for Emergency Department (ED) admissions. A “good admission” was considered an 
admission to the ED in which patients had followed counseling to remain at home up to the point of admission being 
required based on pharmacist’s previous recommendations. A “bad admission” was considered an admission that 
could have been prevented by adhering to pharmacist counseling or receiving pharmacist counseling before 
chemotherapy.
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Question 1: I felt very knowledgeable about 
my chemotherapy regimen before the 
pharmacist counseled me
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Question 2: I felt knowledgeable about 
my chemotherapy regimen after the 
pharmacist counseled me
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Question 3: I knew exactly what to do when I 
had any side effects
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Question 4: The pharmacist helped my 
understand exactly why and how the drugs 
worked
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